As a control, we treated the cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 since inhibition of PI3K/AKT signaling suppresses tumor cell proliferation and NE marker expression in GI carcinoid tumors [14]. Here, AKT1 is linked to neoplasm.